炎症性皮肤病的新非类固醇局部治疗方法-第3部分:罗夫米拉斯
Margaret DiRuggiero1, Elizabeth Mancuso-Stewart2, Douglas DiRuggiero3
1United States Air Force Academy, Colorado Springs, CO.
Skinmed
|September 29, 2023
概括
局部使用的roflumilast是一种新的非类固醇治疗方法,为斑块性牛皮提供强大的固-4抑制作用. 这种FDA批准的疗法为炎症性皮肤疾病提供了新的选择.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 自20世纪50年代以来,局部皮质类固醇一直是炎症性皮肤炎的首要治疗方法.
- 虽然存在非类固醇选择,但没有一个与皮质类固醇的广泛疗效和耐受性相匹配.
- 最近的FDA批准引入了具有不同的机制的新型非类固醇药物.
研究的目的:
- 审查和总结有关炎症性皮肤病的新型非类固醇局部药物的数据.
- 为皮肤科医生提供全面的信息,以便将这些药物整合到治疗范例中.
- 专注于局部的罗夫米拉斯,一种固-4抑制剂,作为系列中的第三种药物.
主要方法:
- 对新的局部药物的临床数据和FDA批准的审查.
- 对作用机制,疗效,安全性和耐受性概况的分析.
- 专注于用于治疗斑块性牛皮的局部罗米拉斯特.
主要成果:
- 此前已批准局部使用的鲁克索利提尼布 (JAK抑制剂) 和局部使用的塔皮纳罗夫 (烯碳化合物受体调节剂).
- 局部使用的罗夫卢米拉斯特是一种强有力的固-4抑制剂,在2022年7月获得了FDA的批准,用于斑块性牛皮.
- 每一种新药物都具有独特的疗效,发病和安全性.
结论:
- 炎症性皮肤病局部治疗的格局随着新的非类固醇药物显著改变.
- 局部使用的罗米拉斯特代表了治疗斑块性牛皮的重大进展.
- 这些新药物为皮肤科医生提供了多样化的患者管理选择.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
289
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
289
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
Drugs Used in Lower Respiratory Disorders: Overview
474
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
474


